Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
https://investor.ironwoodpharma.com/files/doc_news/archive/7065f7c2-86ce-45e6-84d3-711631e69aa5.pdf
Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
https://investor.ironwoodpharma.com/files/doc_news/archive/7065f7c2-86ce-45e6-84d3-711631e69aa5.pdf
Microbia Announces Name Change to Ironwood Pharmaceuticals
https://investor.ironwoodpharma.com/files/doc_news/archive/d6e08fdc-77d1-44d9-8197-3ff4a45d0e77.pdf
Microbia Announces Name Change to Ironwood Pharmaceuticals
https://investor.ironwoodpharma.com/files/doc_news/archive/d6e08fdc-77d1-44d9-8197-3ff4a45d0e77.pdf
Microbia Appoints Halley Gilbert as Vice President, General Counsel
https://investor.ironwoodpharma.com/files/doc_news/archive/aa59cac7-ee72-46c1-a384-77b9ec20fdc5.pdf
Microbia Appoints Halley Gilbert as Vice President, General Counsel
https://investor.ironwoodpharma.com/files/doc_news/archive/aa59cac7-ee72-46c1-a384-77b9ec20fdc5.pdf
Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2B Studies
https://investor.ironwoodpharma.com/files/doc_news/archive/a4881832-4d25-44bd-bf97-5d0abb87d72e.pdf
Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2B Studies
https://investor.ironwoodpharma.com/files/doc_news/archive/a4881832-4d25-44bd-bf97-5d0abb87d72e.pdf